Meningococcal vaccines: a comparative analysis, Opal Bio Pharma posted on the topic

In the endeavor to combat meningococcal disease caused by Neisseria meningitidis, MCV4 and MenB-FHbp vaccines play a critical role, each targeting different…

Quadri Meningo Meningococcal Vaccine, Bio-Med, 1ml at Rs 1150/piece in Surat

Opal Bio Pharma on LinkedIn: #obp #cdc #immunotherapy #vaccine #medicine #genetherapy…

OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans

Biosimilar vaccines regulatory framework: A guide to develop and approve SBPs., Opal Bio Pharma posted on the topic

PDF) Targeting the complement system in bacterial meningitis

Meningococcal disease research: vaccines that protect against serotypes., Opal Bio Pharma posted on the topic

Vaccines, Free Full-Text

Pharmaceutical Benefits Scheme (PBS) Multicomponent Meningococcal Group B Vaccine, 0.5mL, injection, prefilled syringe, Bexsero® - November 2013

Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs, BMC Public Health

JCM, Free Full-Text

Vaccines, Free Full-Text

Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect